🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Purpose :Research into the impact of Qiliqiangxin capsule on IFN-γ，IL-4，NT-...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT02283450
Treatments Being Tested
A prospective, single-center, observational study aiming to assess the pred...
Status
Recruiting
Location
Ippokratio General Hospital
Start Date
2024-06-01
Trial ID
NCT06890013
Treatments Being Tested
The advent of immunotherapy (immune checkpoint inhibitors \[ICI\]) has been...
Status
Active Not Recruiting
Location
Beatson West of Scotland Cancer Centre
Start Date
2022-08-30
Trial ID
NCT06597045
Treatments Being Tested
Heart failure (HF) is the most common nosology encountered in clinical prac...
Status
Recruiting
Location
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Start Date
2023-10-01
Trial ID
NCT05769036
The aim of the study is to evaluate the accuracy and reproducibility of the...
Status
Completed
Location
Universitair Ziekenhuis Brussel
Start Date
2017-11-28
Trial ID
NCT03551158
Treatments Being Tested
Patients with CKD who suspected to have pulmonary hypertension by echocardi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08
Trial ID
NCT07052968
Treatments Being Tested
This study's investigators previously demonstrated the potential utility of...
Status
Active Not Recruiting
Location
Children's Hospital of Orange County
Start Date
2021-10-13
Trial ID
NCT05063435
Treatments Being Tested
It aims to perform a retrospective, multi-center, observational study. All ...
Status
Enrolling By Invitation
Location
Maastricht UMC+
Start Date
2024-01-01
Trial ID
NCT07151989
Treatments Being Tested
The investigator aims to prospectively enroll patients who were referred fo...
Status
Recruiting
Location
Tianjin Chest Hospital
Start Date
2025-01-01
Trial ID
NCT07063147
Treatments Being Tested
Ibrutinib is an irreversible Bruton tyrosine-kinase inhibitor. In prospecti...
Status
Completed
Location
Sestre milosrdnice University Hospital
Start Date
2018-12-01
Trial ID
NCT03751410